Translating basic science discoveries into clinical treatments for autism and other developmental disabilities
Clinical Translational Core
This study is working to create new treatments for autism and other developmental challenges, so that patients can get better diagnoses and access to the latest therapies that really help.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11132928 on NIH RePORTER |
What this research studies
The Clinical Translational Core (CTC) at the University of Wisconsin-Madison focuses on bridging the gap between basic science discoveries and clinical applications. This research aims to develop new treatments and interventions for conditions such as autism spectrum disorder and other intellectual and developmental disabilities. By utilizing state-of-the-art technologies and resources, the CTC supports clinical trials and community practices, ensuring that innovative findings are effectively translated into real-world solutions. Patients may benefit from improved diagnostic evaluations and access to cutting-edge treatments through this initiative.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with autism spectrum disorder or other intellectual and developmental disabilities.
Not a fit: Patients with conditions unrelated to autism or developmental disabilities may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and interventions for individuals with autism and related developmental disabilities.
How similar studies have performed: Previous research has shown success in translating basic science findings into clinical applications for developmental disabilities, indicating a promising path for this initiative.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Dawalt, Leann Smith — University of Wisconsin-Madison
- Study coordinator: Dawalt, Leann Smith
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.